Associate Director Discovery- Oncology
Johnson & Johnson Innovative Medicine
Summary
Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results.
Job description
About Oncology
Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results.
We are searching for the best talent for an Associate Director, in Oncology Discovery, Innovative Medicine, located in Spring House, PA. Join our Oncology In Vivo team and drive the characterization and development of small molecules, biologics, radioligands, antibody-drug conjugates, and cell therapies for the treatment of cancer.
We execute in vivo pharmacology studies within Oncology research programs to meet departmental drug development and strategic objectives, to bring life-changing therapies to the clinic. We characterize potential clinical therapeutics through the evaluation of target inhibition, efficacy, mechanism of action, pharmacokinetic/pharmacodynamics (PK/PD), and biomarker evaluations.
In this role, you will lead other leaders and individual contributors within a collaborative team, interacting with discovery leaders and cross-functional project teams. You will be accountable for effective performance management and meaningful career development conversations.
Key Responsibilities
- Lead the Spring House, PA site team of leaders, and/or individual contributors who collaborate across functions and within teams.
- Guide team by conducting effective performance and career development conversations.
- Lead with vision, setting strategic goals and long-range planning objectives for team.
- Shape team strategy, design of experiments, data interpretation, and communication to teams and collaborators.
- Communicate clearly and expertly, delivering impactful presentations and reports to internal teams and external audiences.
- Collaborate across functions and teams, acting as a scientific resource and leader, identifying key insights from biological experiments and research.
- Operational leadership of the team (e.g., workflow, efficiency improvement, adaptation, and compliance), as well as ensuring achievement of team goals within established timelines and budgets.
- Promote sound scientific method, ensuring data quality, and accurate record creation and retention for self and for team.
- Champion laboratory safety, health and well-being of staff, and compliance with animal welfare standards.
Qualifications/ Requirements
Education: Bachelor’s degree (BS/BA) in the life sciences (molecular/cellular biology, biochemistry, pharmacology, tumor immunology) with at least 15 years pharmaceutical or biotech industry/lab/academic experience OR a Master’s degree (MS) with at least 12 years experience, or PhD with 5-8 years of relevant post-graduate experience.
Experience and Skills
Required:
- Expertise in drug development of Oncology therapeutics.
- Experience in optimally leading individuals and/or teams.
- Experience with oncology-relevant rodent models such as xenografts and syngeneic models, orthotopic models, humanized models, or genetically engineered tumor models.
- Expertise in study design, data analysis, interpretation, and presentation of in vivo pharmacology studies.
- Strong organizational skills including the ability to handle several projects simultaneously; detail oriented with excellent record keeping skills.
- Excellent communication skills including effective interaction with people and teams both internally and externally.
- Presentation of scientific data and concepts to colleagues and teams.
- Proven record of adherence to animal welfare and compliance regulations.
Preferred:
- Experience in writing technical drafts for patent filings, IND (US-FDA) or CTA (EMA) filings.
Requirements
- Bachelor’s degree (BS/BA) in the life sciences (molecular/cellular biology, biochemistry, pharmacology, tumor immunology) with at least 15 years pharmaceutical or biotech industry/lab/academic experience OR a Master’s degree (MS) with at least 12 years experience, or PhD with 5-8 years of relevant post-graduate experience
- Expertise in drug development of Oncology therapeutics
- Experience in optimally leading individuals and/or teams
- Experience with oncology-relevant rodent models such as xenografts and syngeneic models, orthotopic models, humanized models, or genetically engineered tumor models
- Expertise in study design, data analysis, interpretation, and presentation of in vivo pharmacology studies
- Strong organizational skills including the ability to handle several projects simultaneously; detail oriented with excellent record keeping skills
- Excellent communication skills including effective interaction with people and teams both internally and externally
- Presentation of scientific data and concepts to colleagues and teams
- Proven record of adherence to animal welfare and compliance regulations
- Experience in writing technical drafts for patent filings, IND (US-FDA) or CTA (EMA) filings
Company overview
Johnson & Johnson Innovative Medicine is the pharmaceutical division of Johnson & Johnson, leading the way in medical innovation with a relentless focus on bringing transformational treatments to patients worldwide. The company applies rigorous science and compassion to address the most complex diseases of our time, developing groundbreaking medicines across key therapeutic areas including oncology, immunology, neuroscience, and cardiopulmonary medicine. With deep expertise and global reach, Johnson & Johnson Innovative Medicine reimagines how devastating diseases are treated and cured, delivering hope and better care for millions of patients and their families. The organization pioneers the path from laboratory research to clinical application, championing patients every step of the way while maintaining an unwavering commitment to scientific excellence and patient-centered innovation.